Name:
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole)
Type:
Synthetic cannabinoid
AKA:
JWH-019
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) image
Synthetic substance, no natural derivative
IUPAC Logo
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) image
JWH-019, a synthetic cannabinoid, was first synthesized in the early 2000s. It is part of the JWH series, designed to interact with cannabinoid receptors. The compound was explored for its psychoactive effects and appeared in synthetic cannabis products. JWH-019's association with health risks has led to increased regulatory measures.
Synthetic Substances Image
JWH-019 is a synthetic cannabinoid that acts as an upper, producing psychoactive effects similar to cannabis. Short-term use can lead to euphoria and altered perception, while long-term effects are not well understood. Overdose risks include severe psychological effects and potential toxicity. Safe use is uncertain due to limited research. Recent studies focus on its psychoactive properties and associated health risks.
N/A
N/A
N/A
JWH-019 is a synthetic cannabinoid that mimics the effects of THC, the active component in cannabis. Synthetic cannabinoids have emerged as popular alternatives to marijuana, often marketed as 'legal highs.' Their unpredictable effects and high potency have led to numerous health incidents, and they are often associated with marginalized communities seeking affordable highs. Historically, cannabis has been used in religious and medicinal contexts in various cultures, including ancient China and India. The modern use of synthetic cannabinoids like JWH-019 has raised concerns about public health, leading to regulatory crackdowns and ongoing debates about cannabis legalization and the safety of synthetic alternatives.
N/A